Patient Portal

Eric M. Knoche, MD

Assistant Professor, Medicine
Division of Medical Oncology

Specialty Areas

Medical Oncology

Board Certifications

Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Medical oncology, hematology

  • Location(s)
  • Education
  • Publication & Research



Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129



Residency, Internal Medicine: Barnes-Jewish Hospital, St. Louis, MO 2008
Bachelor of Science: Davidson College, Davidson, NC 2001
Chief Resident, Internal Medicine: John Cochrane Veterans Hospital, St. Louis, MO 2009
Medical Degree: Washington University School of Medicine, St. Louis, MO 2006
Fellowship, Hematology and Oncology: Washington University, St. Louis, MO 2014

Publication & Research

Publication & Research

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
Fischer-Valuck BW, Michalski JM, Mitra N, Christodouleas JP, DeWees TA, Kim E, Smith ZL, Andriole GL, Arora V, Bullock A, Carmona R, Figenshau RS, Grubb RL, Guzzo TJ, Knoche EM, Malkowicz SB, Mamtani R, Pachynski RK, Roth BJ, Zaghloul MS, Gay HA, Baumann BC
Cancer Med. 2019 Jul; 8(8)3698-3709. doi: 10.1002/cam4.2102.

    [PubMed - in process]
Related citations

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.
Fischer-Valuck BW, Michalski JM, Contreras JA, Brenneman R, Christodouleas JP, Abraham CD, Kim EH, Arora VK, Bullock AD, Carmona R, Figenshau RS, Grubb R 3rd, Knoche EM, Pachynski RK, Picus J, Roth BJ, Sargos P, Andriole GL, Gay HA, Baumann BC
Clin Transl Radiat Oncol. 2019 Feb; 1538-41. doi: 10.1016/j.ctro.2018.12.001.

Related citations

Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia.
Zhou AW, Knoche EM, Engle EK, Ban-Hoefen M, Kaiwar C, Oh ST
N Engl J Med. 2016 Aug 4; 375(5)494-6. doi: 10.1056/NEJMc1600337.

    [PubMed - indexed for MEDLINE]
Related citations

Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib.
Zhou A, Knoche EM, Engle EK, Fisher DA, Oh ST
Blood Cancer J. 2015 Oct 2; 5e351. doi: 10.1038/bcj.2015.77.

    [PubMed - indexed for MEDLINE]
Related citations